Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 3, 2007

Amylin Selects Ohio as Site for Expansion of Production Plant

  • Amylin is increasing construction at the manufacturing facility in West Chester, OH, to increase investment to a total of approximately $400 million.

    The company is expanding its existing production plant near the Union Center Boulevard district, which is now in the process of being equipped to manufacture it long-acting release (LAR) formulation of exenatide, a compound in development for type 2 diabetes.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »